Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin Levels of Postmenopausal Women With Low Bone Mass: A Multicenter, Randomized, Head-to-head Clinical Trial

NCT01572545 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT01572545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01572545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin Levels of Postmenopausal Women With Low Bone Mass: A Multicenter, Randomized, Head-to-head Clinical Trial
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
January 31, 2013
Enrollment
91 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis